Dr. Reddy's Laboratories Limited
RDY
$13.67
-$0.12-0.87%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.71% | 16.99% | 1.01% | -16.28% | -2.25% |
| Total Depreciation and Amortization | 21.91% | 17.67% | 23.35% | 3.55% | 5.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.27% | 135.29% | -163.34% | 117.26% | 110.26% |
| Change in Net Operating Assets | 39.24% | 120.28% | 19.80% | -394.49% | -58.33% |
| Cash from Operations | 67.85% | 83.18% | 37.72% | -48.70% | -25.62% |
| Capital Expenditure | -30.88% | -40.17% | -84.86% | -101.91% | -38.30% |
| Sale of Property, Plant, and Equipment | -84.40% | -118.09% | -79.12% | -55.50% | 936.53% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.43% | 38.11% | 112.46% | 3,111.61% | -227.25% |
| Cash from Investing | 7.60% | -12.42% | 66.76% | -316.74% | -142.12% |
| Total Debt Issued | -99.34% | -1,404.80% | -64.30% | -- | 178.05% |
| Total Debt Repaid | -8.67% | 4.89% | -143.90% | 25.89% | 93.74% |
| Issuance of Common Stock | 931.58% | -64.52% | 177.78% | -79.88% | -75.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 1.09% | -- |
| Other Financing Activities | -53.63% | -25.71% | -76.38% | 1,356.47% | -31.91% |
| Cash from Financing | -112.29% | -1,226.54% | -88.99% | 326.56% | 736.62% |
| Foreign Exchange rate Adjustments | 914.92% | 446.83% | -103.06% | 65.60% | 118.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.32% | 449.90% | 128.69% | -0.28% | -249.12% |